The board meeting for Lemaitre Vascular Inc is scheduled for today, for the purpose of Oppenheimer 35(th) Annual Healthcare MedTech & Services ConferenceSee details
Lemaitre Vascular Inc has a share price target of US$ 106, revenue growth forecast of 8.8%, and profit growth estimate of 17.2% for FY25, based on top 11 analyst calls.